| News
Basel Area sets new record for new company settlements
24.03.2022
For Basel Area Business & Innovation, 2021 was a record year. Last year, the investment and innovation promotion agency supported the settlement of 39 new businesses and creation of 76 startups in the two Basel cantons and Jura.

The Switzerland Innovation Park Basel Area moves to the neighboring tower at the Novartis Campus (img: Biondopictures)
The support of Basel Area Business & Innovation helped 39 new companies establish themselves in the Basel Area. This exceeds the previous year’s figure of 27 company settlements. As the investment and innovation promotion agency for the cantons of Basel-Landschaft, Basel-Stadt and Jura reported, by far the largest share was attributable to the life sciences sector, with 28 new companies. Seven of them operate in the field of digital health. Five new companies in the region work in production and process technology.
The 39 new companies come from 15 countries. Five are from France and five from the USA, three from the United Kingdom and nine from Swiss cantons outside the Basel Area.
Foundation of 76 startups supported
The agency also supported the foundation of 76 startups in the Basel Area in 2021. While this is six fewer than in the previous year, it is the second highest figure ever achieved. The appeal of the Basel Area for new company settlements was enhanced through venture accelerators and incubators launched by the location promotion such as BaseLaunch (biotech), DayOne (digital health), i4Challenge (industrial transformation) and Venture Monitoring.
The Switzerland Innovation Park Basel Area also saw “pleasing” growth. There are now 68 companies and 14 research groups at its sites in Allschwil in the canton of Basel-Landschaft, Basel, Jura and the Novartis Campus. To make space for the growth of the Innovation Park at the Novartis Campus, this will move to a much bigger neighboring building on 1 April.
Share this article
Sign up to receive our newsletter in your inbox.
You may also be interested in
Cell and gene therapies gain momentum in Basel
Companies specializing in the research and development of innovative cell and gene therapies continue to spring up all around the...
Read MoreBLKB expanding support for startups
BLKB offers particularly promising SMEs and startups financial support within the framework of the “100 fürs Baselbiet” program. These companies...
Read MoreCombatting the rise of antimicrobial resistance
Antimicrobial resistance (AMR) is a growing global threat that, without intervention, could lead to as many as 10 million deaths...
Read MoreAMR Action Fund invests in new antibiotics developed by BioVersys
The AMR Action Fund has made its first European investment in BioVersys, which is headquartered at Tech Park Basel. The...
Read MoreInvestors give Resistell 8.5 million Swiss francs
Resistell AG has secured 8.5 million Swiss francs in the first part of its series B funding round. The biotechnology...
Read MoreBSI integrating AI from Parashift in banking software
Parashift, the specialist in the area of smart document processing on the basis of Artificial Intelligence (AI), has entered into...
Read More